| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5695424 | Gynecologic Oncology Reports | 2017 | 4 Pages |
Abstract
- NACT use among SGO members for ovarian cancer is explored given recent trials.
- Fewer SGO members feel they can't predict optimal cytoreduction pre-operatively.
- Laparoscopy use has increased both for diagnosis and treatment of ovarian cancer.
- Very high optimal cytoreduction rates are reported from SGO members.
- Despite recent studies, SGO members don't regularly treat patients with NACT/ID.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Erica Huelsmann, Israel Zighelboim, Amina Ahmed, Summer Dewdney,